Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient
- An M. T. Van Nuffel, Daphné Benteyn, +5 authors Aude Bonehill
- Cancer Immunology, Immunotherapy
- 2011
Highly Influenced